Literature DB >> 11569774

Limitations in controlling risk for recurrence after curative surgery for advanced gastric cancer are now well-explained by molecular-based mechanisms.

D H Roukos, A M Kappas.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11569774     DOI: 10.1007/s10434-001-0620-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer.

Authors:  Alvaro Díaz de Liaño; Concepción Yarnoz; Rubén Aguilar; Cristina Artieda; Héctor Ortiz
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

2.  Surgical treatment of recurrent gastric cancer.

Authors:  Alvaro Díaz de Liaño; Concepción Yarnoz; Rubén Aguilar; Cristina Artieda; Héctor Ortiz
Journal:  Gastric Cancer       Date:  2008-03-29       Impact factor: 7.370

3.  Identification of hsa-miR-335 as a prognostic signature in gastric cancer.

Authors:  Zhi Yan; Yimin Xiong; Weitian Xu; Juan Gao; Yi Cheng; Zhigang Wang; Fang Chen; Guorong Zheng
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

4.  Prognostic factors for gastrectomy in elderly patients with gastric cancer.

Authors:  Daisuke Ueno; Hideo Matsumoto; Hisako Kubota; Masaharu Higashida; Takashi Akiyama; Akiko Shiotani; Toshihiro Hirai
Journal:  World J Surg Oncol       Date:  2017-03-11       Impact factor: 2.754

5.  Effect of tissue factor knockdown on the growth, invasion, chemoresistance and apoptosis of human gastric cancer cells.

Authors:  Yong-Jiang Yu; Xu-Dong Hou; Yu-Min Li
Journal:  Exp Ther Med       Date:  2014-02-28       Impact factor: 2.447

6.  Downregulated miRNA-1269a variant (rs73239138) decreases the susceptibility to gastric cancer via targeting ZNF70.

Authors:  Wenshuai Li; Huilu Zhang; Pei Min; Jie Zhu; Diannan Xu; Weiru Jiang; Yanyun Ma; Jigang Qiu; Weihong Xu; Jian Chen; Mingqing Zhang; Min Li; Dongqin Yang; Jianping Shi; Jun Zhang; Jie Liu
Journal:  Oncol Lett       Date:  2017-09-28       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.